NuPathe Inc. (NASDAQ: PATH) announced financial results for the quarter ended June 30, 2011 and recent operational highlights. "In the second quarter we continued to make significant progress in preparing for the commercial launch of our migraine patch and we remain firmly on track for a product launch in the first half of 2012. We had a large presence at the American and International Headache Society meetings in June where we presented clinical data on our migraine patch indicating consistent relief of headache pain and nausea from migraine attacks over a 12-month period," said Jane Hollingsworth, chief executive officer of NuPathe.
Read more at: http://crwewallstreet.com/?p=21029